~~<i id='A943FCA1FB'><strike id='A943FCA1FB'><tt id='A943FCA1FB'><pre id='A943FCA1FB'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：Wikipedia 2025-09-29 03:14:55 Page View：82467

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Coloradans with cystic fibrosis could lose access to Trikafta
Next article： Psychedelics group wrestles with new pharma identity

explore

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Sarepta Duchenne therapy fails to meet primary endpoint in trial

RubyWallauforSTATSareptaTherapeuticssaidMondayafternoonthatitsgenetherapyforDuchennemusculardystroph

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Inari Medical to buy amputation prevention company LimFlow

Inariwillpay$250millionupfrontand$165moredependingonLimFlow’scommercialsuccess.DavidGregory&Debb